Alaethes Wealth LLC Acquires 130 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Alaethes Wealth LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,777 shares of the healthcare conglomerate’s stock after acquiring an additional 130 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Alaethes Wealth LLC’s investment portfolio, making the stock its 25th largest holding. Alaethes Wealth LLC’s holdings in UnitedHealth Group were worth $2,433,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Legacy Financial Advisors Inc. increased its stake in shares of UnitedHealth Group by 1.5% in the second quarter. Legacy Financial Advisors Inc. now owns 5,306 shares of the healthcare conglomerate’s stock worth $2,702,000 after buying an additional 77 shares during the period. 11 Capital Partners LP bought a new position in shares of UnitedHealth Group during the second quarter valued at about $18,486,000. Ensign Peak Advisors Inc grew its stake in shares of UnitedHealth Group by 2.8% in the second quarter. Ensign Peak Advisors Inc now owns 1,685,447 shares of the healthcare conglomerate’s stock worth $858,331,000 after purchasing an additional 45,481 shares during the last quarter. Westwood Holdings Group Inc. raised its position in UnitedHealth Group by 3.2% during the 2nd quarter. Westwood Holdings Group Inc. now owns 233,481 shares of the healthcare conglomerate’s stock valued at $118,903,000 after purchasing an additional 7,155 shares during the last quarter. Finally, Bulltick Wealth Management LLC increased its stake in shares of UnitedHealth Group by 44.0% during the second quarter. Bulltick Wealth Management LLC now owns 16,717 shares of the healthcare conglomerate’s stock valued at $8,513,000 after buying an additional 5,111 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH stock opened at $575.00 on Friday. The company has a market cap of $529.22 billion, a P/E ratio of 35.15, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The stock’s fifty day moving average price is $577.10 and its 200-day moving average price is $520.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the firm earned $6.14 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Argus lifted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Barclays increased their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial upped their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $614.17.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.